BTAI
BioXcel Therapeutics, Inc.
$0.80
-0.24 (-22.87%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$24.77M
Shares
30,877,605
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.80
Open$1.04
Day$0.79–1.04
52W$0.79–8.08
Avg vol 30d1.1M
Short int4.3M · 14.0% float · 6.9d
Short vol54%
Last earningsMay 15, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−52%
below
Price vs 50-day avg
−32%
below
RSI (14)
29
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−61%
trailing
YTD return
−50%
this year
Relative strength
−68%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +8 funds added
Insider flow
Distributing
Net -$43.1K over 90 days · 100% sells
Short interest
Rising
13.98% of float · ▲ +22.4% MoM · 6.9 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
40 holders — near 1-yr high, broad support
Squeeze score
80
high risk · 0–100
Fundamentals
Revenue growth
−72%
Y/Y
EPS growth
+76%
Y/Y
Free cash flow
$-57.6M
Balance sheet
$81.2M
net debt
Quant / Vol
risk profile
Volatility
143%
annualized · 1-yr
Max drawdown
−88%
past year
ATR
13.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 24, 2026
Est · unconfirmed
· in 7 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−52%
Bearish
Price vs 50-day avg
−32%
Bearish
RSI (14)
29
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-2% holders QoQ · +8 funds added
Insider flow
Distributing
Net -$43.1K over 90 days · 100% sells
Short interest
Rising
13.98% of float · ▲ +22.4% MoM · 6.9 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
40 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 0%
52-wk high $8
vs 200-day avg -52%
vs 50-day avg -32%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BTAI
this stock
BioXcel Therapeutics, Inc.
|
$24.77M | -49.9% | -71.7% | — | 14.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.49B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.94B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BTAI | -43.1% | -27.4% | -60.9% | -43.1% | -49.9% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -42.9% | -28.2% | -68.3% | -42.9% | -59.2% |